Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants

Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants

Item
http://www.wikidata.org/entity/Q28473083
Intermittent preventive treatment for malaria in infantsIntermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trialProtective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.Intermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and deliveryModelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.Intermittent preventive treatment of malaria in children: a qualitative study of community perceptions and recommendations in Burkina Faso and Mali.Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review.Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.Follow-up survey of children who received sulfadoxine-pyrimethamine for intermittent preventive antimalarial treatment in infantsCluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival.Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa.A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.Intermittent preventive treatment against malaria: an update.Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum.Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children.
P2860

Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants

Item
http://www.wikidata.org/entity/Q28473083
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Duration of protection against ...... treatment in Tanzanian infants
@ast
Duration of protection against ...... treatment in Tanzanian infants
@en
Duration of protection against ...... treatment in Tanzanian infants
@nl
type
label
Duration of protection against ...... treatment in Tanzanian infants
@ast
Duration of protection against ...... treatment in Tanzanian infants
@en
Duration of protection against ...... treatment in Tanzanian infants
@nl
prefLabel
Duration of protection against ...... treatment in Tanzanian infants
@ast
Duration of protection against ...... treatment in Tanzanian infants
@en
Duration of protection against ...... treatment in Tanzanian infants
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Duration of protection against ...... treatment in Tanzanian infants
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0009467
P407
P433
P478
P50
P577
P5875
P698
P921
P932